Company: PFSA
Filing Date: 2025-08-21
Form Type: S-1/A
Source: 0001213900-25-079401
Chunk: 392

Company: Profusa, Inc.
Filing Date: 2025-08-21
Form: S-1/A
Chunk 392
---
 equity -linkedofferings, and shall be calculated from F-102 NORTHVIEW ACQUISITION CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS Note 6 — Commitments and Contingencies (cont.) the face value of notes issued, which is payable at the close of a Business Combination. On June 17, 2025, the Company entered a settlement agreement with A.G.P. for the Cash Fee of $ 968,000related to the debt private placement (the “Offering”) that was issued at the Closing. Pursuant to the settlement agreement, as a result of the Business Combination, the Company paid A.G.P. $ 550,000at the Closing and the remaining $ 418,000of the fees was deferred and due on the earlier of (i) the second tranche of the debt private placement being issued and (ii) December 31, 2025. The Company also agreed to reimburse A.G.P. $ 50,000for expenses incurred in connection with the offering. On June 15, 2023, the Company engaged the Benchmark Company LLC (“Benchmark”) to provide advisory services related to the Business Combination and the Convertible Notes. The Company was to pay Benchmark at the closing of the Business Combination an advisory fee of $ 750,000in two tranches. The first tranche will be $ 500,000earned upon the closing of the Business Combination in the surviving public entity’s common stock (“Tranche 1”). The number of shares to be issued is calculated on the 30 thday following the Closing by dividing $ 500,000and the trailing 5 -dayVWAP of the Company’s common stock as calculated by Bloomburg with a minimum price of $ 2.00. The second tranche will be $ 250,000, at the Company’s option, in either cash or in the surviving entity’s common shares calculated by dividing $ 250,000by the lowest trailing 5 -dayVWAP in the prior 30 days (“Tranche 2”). Upon funding of the Convertible Notes by investors introduced by Benchmark, the Company will pay to Benchmark fees in cash equal to 5% of the net proceeds of any Convertible Note draw at the time of funding of such draw (“Arrangement Fees”). The Tranche 2 fee shall be reduced by the amount of any fees paid to Benchmark for other transactions during the Term other than Arrangement Fees associated with